Persistence with inhaled corticosteroid therapy in daily practice
نویسندگان
چکیده
منابع مشابه
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
BACKGROUND Inhaled corticosteroids (ICS) are effective maintenance treatments for childhood asthma; however, many children remain uncontrolled. Vilanterol (VI) is an inhaled long-acting beta-2 agonist which, in combination with the ICS fluticasone furoate, is being explored as a once-daily treatment for asthma in children. We evaluated the dose-response, efficacy, and safety of once-daily VI (6...
متن کاملPosterior subcapsular cataract and inhaled corticosteroid therapy.
BACKGROUND Although posterior subcapsular cataract complicates both systemic and topical corticosteroid therapy, the literature on the effects of inhaled corticosteroids is conflicting. METHODS One hundred and forty children and young adults on inhaled corticosteroids were examined by slit lamp ophthalmoscopy after pupillary dilatation; 103 had received one or more short courses (< or = 7 day...
متن کاملHigher persistence with valsartan compared with enalapril in daily practice
OBJECTIVE To compare persistence with valsartan and enalapril in daily practice. METHODS The PHARMO Record Linkage System includes various data registries including drug dispensing and hospitalizations for > or =2 million subjects in the Netherlands. Patients newly treated with valsartan or enalapril in the period of 1999-2002 were selected. Persistence was calculated by summing up the number...
متن کاملLong term persistence with statin treatment in daily medical practice.
S tatin treatment is a safe and effective method of reducing cardiovascular events in both primary and secondary prevention. 2 Persistence with statin use in trials is generally high. Analysis of the WOSCOPS (west of Scotland coronary prevention study) showed that the efficacy of pravastatin depends on compliance. Although long term persistence with statin treatment in elderly patients has been...
متن کاملInhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide.
Inhaled corticosteroids (ICSs) are recommended for patients with asthma who use a short-acting beta(2)-adrenergic agonist more than twice weekly--a key indicator of disease persistency. Much knowledge about the long-term benefits of ICSs in persistent asthma stems from studies of the ICS budesonide, which have shaped current asthma guidelines. Results of the 3-year double-blind phase of the inh...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Respiratory Medicine
سال: 2004
ISSN: 0954-6111
DOI: 10.1016/j.rmed.2004.01.014